These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
776 related articles for article (PubMed ID: 19638254)
1. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis. Cruz N; Sanchez-Moreno J; Torres F; Goikolea JM; Valentí M; Vieta E Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254 [TBL] [Abstract][Full Text] [Related]
3. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346 [TBL] [Abstract][Full Text] [Related]
4. Second-generation antipsychotics for major depressive disorder and dysthymia. Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393 [TBL] [Abstract][Full Text] [Related]
5. Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Taylor DM; Cornelius V; Smith L; Young AH Acta Psychiatr Scand; 2014 Dec; 130(6):452-69. PubMed ID: 25283309 [TBL] [Abstract][Full Text] [Related]
6. Typical and atypical antipsychotics in bipolar depression. Gao K; Gajwani P; Elhaj O; Calabrese JR J Clin Psychiatry; 2005 Nov; 66(11):1376-85. PubMed ID: 16420074 [TBL] [Abstract][Full Text] [Related]
7. Treatment of bipolar disorder: the evolving role of atypical antipsychotics. Perlis RH Am J Manag Care; 2007 Nov; 13(7 Suppl):S178-88. PubMed ID: 18041879 [TBL] [Abstract][Full Text] [Related]
8. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. Goikolea JM; Colom F; Torres I; Capapey J; Valentí M; Undurraga J; Grande I; Sanchez-Moreno J; Vieta E J Affect Disord; 2013 Jan; 144(3):191-8. PubMed ID: 23089129 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder. Taneja C; Papakostas GI; Jing Y; Baker RA; Forbes RA; Oster G Ann Pharmacother; 2012 May; 46(5):642-9. PubMed ID: 22550279 [TBL] [Abstract][Full Text] [Related]
10. Treatment options for bipolar depression: a systematic review of randomized, controlled trials. Vieta E; Locklear J; Günther O; Ekman M; Miltenburger C; Chatterton ML; Aström M; Paulsson B J Clin Psychopharmacol; 2010 Oct; 30(5):579-90. PubMed ID: 20814319 [TBL] [Abstract][Full Text] [Related]
11. A review of sensitivity and tolerability of antipsychotics in patients with bipolar disorder or schizophrenia: focus on somnolence. Gao K; Ganocy SJ; Gajwani P; Muzina DJ; Kemp DE; Calabrese JR J Clin Psychiatry; 2008 Feb; 69(2):302-9. PubMed ID: 18211129 [TBL] [Abstract][Full Text] [Related]
12. Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed. Citrome L Postgrad Med; 2010 Jul; 122(4):39-48. PubMed ID: 20675970 [TBL] [Abstract][Full Text] [Related]
13. Bipolar depression: a new role for atypical antipsychotics? Keck PE Bipolar Disord; 2005; 7 Suppl 4():34-40. PubMed ID: 15948765 [TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Calabrese JR; Keck PE; Macfadden W; Minkwitz M; Ketter TA; Weisler RH; Cutler AJ; McCoy R; Wilson E; Mullen J Am J Psychiatry; 2005 Jul; 162(7):1351-60. PubMed ID: 15994719 [TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics in the treatment of mania: a meta-analysis of randomized, placebo-controlled trials. Perlis RH; Welge JA; Vornik LA; Hirschfeld RM; Keck PE J Clin Psychiatry; 2006 Apr; 67(4):509-16. PubMed ID: 16669715 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883 [TBL] [Abstract][Full Text] [Related]
17. The role of second-generation antipsychotic monotherapy in the rapid control of acute bipolar mania. Keck PE J Clin Psychiatry; 2005; 66 Suppl 3():5-11. PubMed ID: 15762829 [TBL] [Abstract][Full Text] [Related]
18. [Augmentation of antidepressants with atypical antipsychotics in non-delusional unipolar depressed patients with non-response to antidepressant-monotherapy]. Erbe S; Gutwinski S; Bschor T Psychiatr Prax; 2012 Mar; 39(2):57-63. PubMed ID: 22189902 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of treatments for bipolar depression. Vázquez GH; Holtzman JN; Tondo L; Baldessarini RJ J Affect Disord; 2015 Sep; 183():258-62. PubMed ID: 26042634 [TBL] [Abstract][Full Text] [Related]
20. Treatment of bipolar depression: making sensible decisions. Citrome L CNS Spectr; 2014 Dec; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]